The Potential of Cancer Biomarkers
From Discovery to Clinical Application
- 1st Edition - April 14, 2025
- Imprint: Elsevier
- Editor: Pranav Kumar Prabhakar
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 2 9 2 7 9 - 8
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 9 2 8 0 - 4
The Potential of Biomarkers: From Discovery to Clinical Application addresses the challenges related to knowledge dissemination, interdisciplinary understanding, diagnostic comple… Read more
Purchase options
The Potential of Biomarkers: From Discovery to Clinical Application addresses the challenges related to knowledge dissemination, interdisciplinary understanding, diagnostic complexity, quality assurance, patient care, research advancement, education, and professional development within the field of clinical biochemistry. The book provides a holistic solution by offering comprehensive insights and practical guidance to a diverse audience, contributing to the enhancement of healthcare and biomedical research. Each chapter explores the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.
Cancer biomarkers, the molecular signatures of cancer, hold immense promise in revolutionizing how we diagnose, treat, and personalize therapies for cancer patients. In this curated reference, esteemed contributors explore the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.
Cancer biomarkers, the molecular signatures of cancer, hold immense promise in revolutionizing how we diagnose, treat, and personalize therapies for cancer patients. In this curated reference, esteemed contributors explore the multifaceted landscape of biomarker research, offering a wealth of insights and expertise in genomics, proteomics, metabolomics, and more.
- Presents the impact of biomarkers on early detection, prognosis, and personalized treatment strategies
- Incudes ethical and regulatory considerations surrounding biomarker use, guiding policymakers and ethicists through the complex terrain of biomarker-driven healthcare decisions
- Highlights the clinical relevance of cancer biomarkers by showcasing real-world case studies and examples of how biomarkers have been utilized to improve cancer diagnosis, personalize treatment plans, and monitor treatment responses
Healthcare professionals, clinical laboratory technicians, researchers, educators, clinicians in specialties, anyone in the field of clinical biochemistry
1. Introduction: Navigating the Landscape of Cancer Biomarkers
2. Understanding the Role of Biomarkers in Cancer
3. Tools and Technologies for Biomarker Discovery
4. Genomic Biomarkers: Unraveling the DNA of Cancer
5. Proteomics and Protein Biomarkers in Oncology
6. Metabolomics: Metabolic Signatures in Cancer Biomarkers
7. Biomarker Validation and Regulatory Pathways
8. Clinical Trials and Studies for Biomarker Evaluation
9. Early Detection and Diagnostic Biomarkers
10. Prognostic Biomarkers: Predicting Disease Outcomes
11. Predictive Biomarkers: Guiding Personalized Cancer Therapies
12. Monitoring Treatment Response with Biomarkers
13. Ethical Considerations in Biomarker Research and Application
14. Challenges and Future Directions in Biomarker Development
15. Success Stories: Impactful Applications of Cancer Biomarkers
16. The Road Ahead: Advances and Innovations in Biomarker Science
2. Understanding the Role of Biomarkers in Cancer
3. Tools and Technologies for Biomarker Discovery
4. Genomic Biomarkers: Unraveling the DNA of Cancer
5. Proteomics and Protein Biomarkers in Oncology
6. Metabolomics: Metabolic Signatures in Cancer Biomarkers
7. Biomarker Validation and Regulatory Pathways
8. Clinical Trials and Studies for Biomarker Evaluation
9. Early Detection and Diagnostic Biomarkers
10. Prognostic Biomarkers: Predicting Disease Outcomes
11. Predictive Biomarkers: Guiding Personalized Cancer Therapies
12. Monitoring Treatment Response with Biomarkers
13. Ethical Considerations in Biomarker Research and Application
14. Challenges and Future Directions in Biomarker Development
15. Success Stories: Impactful Applications of Cancer Biomarkers
16. The Road Ahead: Advances and Innovations in Biomarker Science
- Edition: 1
- Published: April 14, 2025
- Imprint: Elsevier
- Language: English
PP
Pranav Kumar Prabhakar
Dr. Pranav Kumar Prabhakar is currently working as a Professor in the Department of Biotechnology at Nagaland University, Kohima, Nagaland, India. He has been listed among the World’s Top 2% Scientists (as published by Stanford University, USA, in 2021, 2022, 2023, and 2024). He earned his PhD in Biotechnology from IIT Madras. His primary research interests include elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. He is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He also serves as an editorial board member and reviewer for several reputed national and international journals. Dr. Pranav has received various honors, including a travel grant to attend ATTD 2009 in Greece, sponsored by the Indian Institute of Technology Madras and the Council for Scientific and Industrial Research (CSIR), and approved by the Department of Science and Technology (DST). He has published over 115 research articles in journals, authored or edited 17 books, contributed more than 40 book chapters, and delivered 9 oral and poster presentations at scientific meetings.
Affiliations and expertise
Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, IndiaRead The Potential of Cancer Biomarkers on ScienceDirect